Thousands of people at risk of blindness will be spared monthly injections by new medication called faricimab, which will be offered to patients being treated for advanced retinal vein occlusion. Thousands of people at risk of blindness will be spared monthly injections by new medication called faricimab, which will be offered to patients being treated for advanced retinal vein occlusion.
New drug approved by NHS chiefs will mean thousands of people at risk of blindness will no longer have to take monthly injections
